COMBINATION THERAPY FOR JOINT HYPERMOBILITY SYNDROME
Issue:
12
Year:
2015
In patients with joint hypermobility syndrome, several factors, such as reduced pain threshold and lower bone mineral density, connective tissue structural weakness that leads to permanent joint soft tissue microtraumas and pain, play a role in the pathogenesis of arthralgias. Osteomed stimulates collagen production, reinforces connective tissue structures, and increases pain threshold, contributing to a prompt reduction in the degree of pain syndrome (after 1-month drug administration) and its steady-state relief (after 3-month therapy).
Keywords:
joint hypermobility syndrome
pain syndrome
Osteomed
References:
- Castori M. Joint hypermobility syndrome (a.k.a. Ehlers–Danlos Syndrome, Hypermobility Type): an updated critique // G. Ital. Dermatol. Venereol. – 2013; 148 (1): 13–36.
- Hakim A., Sahota A. Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue // Clin. Dermatol. – 2006; 24 (6): 521–33.
- Viktorova I.A., Kiseleva D.S., Konshu N.V. Taktika vedenija molodyh patsientov s sindromom gipermobil'nosti sustavov vrachom obschej praktiki // Sib. med. obozrenie. – 2011; 6 (72): 103–4.
- Viktorova I.A., Konshu N.V., Rumjantsev A.V. Cindrom gipermobil'nosti sustavov: klinicheskoe znachenie, prognoz, vzaimosvjaz' s riskom vozniknove-nija osteoartroza // Arhiv' vnutrennej meditsiny. – 2015; 2 (22): 3–8
- Dats L.S. i dr. Prognozirovanie oslozhnenij pri sindrome gipermo- bil'nosti sustavov u podrostkov // Sib. med. zhurn. – 2012; 113 (6): 38–40.
- Grahame R., Bird H., Child A. The revised (Brighton, 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS) // J. Rheum. – 2000; 27 (7): 1777–9.
- Strukov V.I. i dr. Izvestnye i novye tehnologii v lechenii i profi laktike osteoporoza. Osteomed – effektivnyj reguljator kal'tsievogo obme-na. Uch. posobie / Penza, 2011
